2012
DOI: 10.1183/09031936.00095712
|View full text |Cite
|
Sign up to set email alerts
|

Chronic beryllium disease: azathioprine as a possible alternative to corticosteroid treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Steroid-sparing agents should be considered in patients with progressive disease or those requiring high-dose corticosteroid therapy. 32,62,66 Infliximab was shown to affect the pulmonary immune response, improve quality of life measures, and have its greatest effect on those with a low diffusing capacity of the lung for carbon monoxide in a small clinical trial. 67 The role that avoidance of further beryllium exposure plays in preventing disease progression remains unclear.…”
Section: Chronic Beryllium Diseasementioning
confidence: 99%
“…Steroid-sparing agents should be considered in patients with progressive disease or those requiring high-dose corticosteroid therapy. 32,62,66 Infliximab was shown to affect the pulmonary immune response, improve quality of life measures, and have its greatest effect on those with a low diffusing capacity of the lung for carbon monoxide in a small clinical trial. 67 The role that avoidance of further beryllium exposure plays in preventing disease progression remains unclear.…”
Section: Chronic Beryllium Diseasementioning
confidence: 99%
“…Out of these risk factors, the genetic susceptibility of the individuals is shown to be the dominant contributor in the development of CBD [2], [8], [9]. Understanding the molecular mechanism of CBD would help prevention and treatment of disease [10], [11], [12], [13], [14].…”
Section: Introductionmentioning
confidence: 99%